The charisma of "Magic Bullets"-monoclonal antibodies (mAB/moAB) in clinical medicine

Journal, Indian Academy of Clinical Medicine

Volumn 12, Issue 4, 2011, Pages 283-289

  Acharya, Sourya ^a   Shukla, Samarth ^a   Mahajan, S N ^a   Diwan, S K ^a  

^a DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antibody; Clone; Immune cell; Monoclonal; Nomenclature

Indexed keywords

ABCIXIMAB; ADALIMUMAB; ALEMTUZUMAB; BEVACIZUMAB; CAPROMAB PENDETIDE IN 111; DACLIZUMAB; DIGOXIN ANTIBODY F(AB) FRAGMENT; EPRATUZUMAB; ETANERCEPT; ETARACIZUMAB; GEMTUZUMAB; GEMTUZUMAB OZOGAMICIN; IBRITUMOMAB TIUXETAN; IMCIROMAB PENTETATE; INFLIXIMAB; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LYM 1; NATALIZUMAB; NOFETUMOMAB MERPENTAN TC 99M; OKT 3; OMALIZUMAB; PYROPHOSPHATE TECHNETIUM TC 99M; RECOMBINANT ANTIBODY; RITUXIMAB; THYMIDINE; TOSITUMOMAB; TRASTUZUMAB;

ACUTE GRAFT REJECTION; ACUTE GRANULOCYTIC LEUKEMIA; AFFINITY CHROMATOGRAPHY; ALLERGIC ASTHMA; ANTIBODY PRODUCTION; B CELL LEUKEMIA; B CELL LYMPHOMA; CELL CULTURE; CELL FUSION; CELL GROWTH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; DRUG BINDING; GENETIC ENGINEERING; HEART INFARCTION; HISTORY OF MEDICINE; HUMAN; HYBRID; HYBRIDOMA; IMAGING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; ISOTOPE LABELING; LYMPHOMA; MULTIPLE MYELOMA; MULTIPLE SCLEROSIS; MYELOMA; MYELOMA CELL; MYOCARDITIS; NEUROLOGY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PROCEDURES; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SOLID TUMOR; SPLEEN CELL; STENT; T CELL LYMPHOMA; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; WESTERN BLOTTING;

EID: 84856254761     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. AMA (USAN) Monoclonal antibodies. United States Adopted Names (2007-08-07). Retrieved on 2007-08-15.
2. "Guidelines on the Use of International Nonproprietary Names (INNs) for Pharmaceutical Substances" (PDF) 27-28 (1997). Retrieved on 2007-08-15.
3. Schwaber J, Cohen EP. Human x Mouse Somatic Cell Hybrid Clones Secreting Immunoglobulins of Both Parental Types. Nature 1973; 244: 444-7.
4. Cambrosio A, Keating P. Between fact and technique: The beginnings of hybridoma technology. Journal of the History of Biology 25 (2): 175-230.
5. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-7. Reproduced in J Immunol 2005; 174: 2453-5.
6. Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature 1988; 332: 323-7.
7. Siegel DL. "Recombinant monoclonal antibody technology". Transfusion clinique et biologique. Journal de la Société Française de Transfusion Sanguine 2002; 9 (1): 15-22.
8. Schmitz U, Versmold A, Kaufmann P, Frank HG. "Phage display: a molecular tool for the generation of antibodies - a review". Placenta 2000; 21 (Suppl A): S106-12.
9. Rang HP. Edinburgh: Churchill Livingstone, for the examples infliximab, basiliximab, abciximab, daclizumab, palivusamab, palivusamab, gemtuzumab, alemtuzumab, etanercept and rituximab, and mechanism and mode of action. Pharmacology 2002; page 241.
10. Milstein C, Cuello AC. Hybrid hybridomas and their use in immunohistochemistry. Nature 305 (5934): 537-40.
11. Takeda S, Naito T, Hama K et al. Construction of chimeric processed immunoglobulin genes containing mouse variable and human constant region sequences. Nature 1985; 314 (6010): 452-4.
12. Cosimi AB, Burton RC, Colvin RB et al. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 1981; 32 (6): 535-9.
13. Epenetos AA, Canti G, Taylor-Papadimitriou J et al. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet 1982; 2 (8306): 1004-6.
14. Haber E, Katus HA, Hurrell JG et al. Detection and quantification of myocardial cell death: application of monoclonal antibodies specific for cardiac myosin. J Mol Cell Cardiol 1982; 14 (Suppl 3): 139-46.
15. Haber et al. In vivo diagnostic and therapeutic uses of monoclonal antibodies in cardiology. Annu Rev Med 1986; 37: 249-61.
16. Arzin MA. Uses of antibodies in clinical cardiology. Am Heart J 1992; 124 (3): 753-68.
17. Lutterotti A, Martin R. Getting specific monoclonal antibody in MS. The Lancet Neurology 7 (6): 538-47.
18. Miller DM et al. Monoclonal Antibodies Promote Central Nervous System Repair in Animal Model of MS. Journal of Neuroscience 1994; 14 (10): 6230-38.
19. Bowes MP, Zivin JA, Rothlein R. Monoclonal antibody to the ICAM- 1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp Neurol 1993; 119: 215-9.